Sponsor Pipeline

Affiliated Cancer Hospital of Shantou University Medical College Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07104604
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab…		 Primary endpoint(s) modified
Active Trials by Phase
Phase 4
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07020468 Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer Colorectal Cancer (CRC) Active, Not Recruiting
Phase 2
NCT07104604 Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab… Rectal Cancer Recruiting
Phase 1
NCT05984342 Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal… Esophageal Squamous Cell Carcinoma Recruiting
Disease Areas
Colorectal Cancer (2)
Get alerts when Affiliated Cancer Hospital of Shantou University Medical College's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free